China now has its own cutting-edge pharma industry, creating opportunities and competition for big pharma players.
China has become a growing source of new drug candidates for big pharmaceutical companies.
Sun Fanyue / AFP
For decades, China was known for producing cheap copycat drugs and ingredients for large pharmaceutical firms. But it now has its own cutting-edge drug industry, creating opportunities and competition for big pharma players like Swiss firms Roche and Novartis.
Generated with artificial intelligence.
This content was published on
Amid systemic efficiency and a wave of innovation, the country’s biotech sector is expanding at a pace that has caught the market…
China has become a pharma powerhouse, but local firms still face a steep climb toward financial stability and global growth.
Bristol Myers’ alliance with Hengrui ranks as the second-largest licensing pact of its kind since the start of 2025, trailing…
‘If we’re not careful, every drug could be made in China,’ warned former head of US Food and Drug Administration in May.
Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next level?
With more drugs in clinical trials than any other country, Chinese drugmakers are now shifting focus to the high-risk,…
